Exploring the evolving landscape of kratom — from regulatory developments and scientific research to industry news and consumer safety.
NIH-supported kratom research is advancing toward a human safety study of mitragynine. Learn what this scientific milestone means for kratom research in the United States.
Read Article
Rhode Island replaced its kratom prohibition with a regulated licensing system. Learn how the Rhode Island Kratom Act protects adults and establishes rules for legal kratom sales.
Read Article
The FDA has distinguished concentrated 7-OH opioid products from natural kratom leaf. Learn why this matters for responsible kratom consumers, retailers and manufacturers.
Read Article
South Carolina passed a Kratom Consumer Protection Act establishing age restrictions, product standards and labeling rules for legal kratom sales.
Read Article
Oregon requires registered kratom processors to certify that their products undergo third-party testing. Learn how Oregon's kratom rules improve transparency.
Read Article
Thirty states and Washington, D.C., regulated kratom or its components as of January 2026. Learn how kratom laws are shifting toward consumer protection.
Read Article
Third-party GMP audits are helping kratom manufacturers improve testing, labeling, sanitation and product traceability across the U.S. market.
Read Article
FDA enforcement is targeting concentrated 7-OH products that are sometimes marketed as kratom. Learn why this distinction matters for natural kratom consumers.
Read Article
New kratom research is examining how mitragynine and dozens of other kratom alkaloids interact with human receptors. Learn why better science matters.
Read Article